Skip to content
ppharmaranks
Menu

IBRANCE vs TASIGNA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. IBRANCE and TASIGNA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

64/100
70/100

Pharmacy pays

Type

RX
RX

Active ingredient

PALBOCICLIB
NILOTINIB HYDROCHLORIDE

Manufacturer

Dosage forms

Capsule, Tablet
Capsule

Drug class

Kinase Inhibitor
Kinase Inhibitor

Boxed warning

Treats

Breast Neoplasms
Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

Frequently asked questions

Which is better-rated, Ibrance or Tasigna?

By our independent rating, Tasigna scores higher — 3.5 vs 3.2 out of 5 for Ibrance. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Ibrance and Tasigna?

Ibrance contains Palbociclib, while Tasigna contains Nilotinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.